Curcumin Extract Improves Beta Cell Functions in Obese Patients with Type 2 Diabetes: a Randomized Controlled Trial

Overview

Journal Nutr J

Publisher Biomed Central

Specialty Nutritional Sciences

Date 2024 Oct 1

PMID 39354480

Authors

Metha Yaikwawong

Laddawan Jansarikit

Siwanon Jirawatnotai

Somlak Chuengsamarn

Affiliations

Soon will be listed here.

Abstract

Background: Type 2 diabetes mellitus (T2DM) is a chronic condition characterized by insulin resistance and impaired insulin production, leading to elevated blood glucose levels. Curcumin, a polyphenolic compound from Curcuma longa, has shown potential in improving insulin sensitivity and reducing blood glucose levels, which may help mitigate type 2 diabetes progression.

Objective: To assess the efficacy of improving type 2 diabetes (T2DM).

Study Design: This randomized, double-blind, placebo-controlled trial included subjects (n = 272) with criteria for type 2 diabetes.

Methods: All subjects were randomly assigned to receive curcumin (1500 mg/day) or placebo with blind labels for 12 months. To assess the improvement of T2DM after curcumin treatments body weight and body mass index, fasting plasma glucose, glycosylated hemoglobin A β-cell function (homeostasis model assessment [HOMA-β]), insulin resistance (HOMA-IR), insulin, adiponectin, and leptin were monitored at the baseline and at 3-, 6-, 9-, and 12-month visits during the course of intervention.

Results: After 12 months of treatment, the curcumin-treated group showed a significant decrease in fasting blood glucose (115.49 vs.130.71; P < 0.05), HbA (6.12 vs. 6.47; P < 0.05). In addition, the curcumin-treated group showed a better overall function of β-cells, with higher HOMA-β (136.20 vs. 105.19; P < 0.01) The curcumin-treated group showed a lower level of HOMA-IR (4.86 vs. 6.04; P < 0.001) and higher adiponectin (14.51 vs. 10.36; P < 0.001) when compared to the placebo group. The curcumin-treated group also showed a lower level of leptin (9.42 vs. 20.66; P < 0.001). Additionally, body mass index was lowered (25.9 4 vs.29.34), with a P value of 0.001.

Conclusions: A 12-month curcumin intervention in type 2 diabetes patients shows a significant glucose-lowering effect. Curcumin treatment appeared to improve the overall function of β-cells and reduce both insulin resistance and body weight, with very minor adverse effects. Curcumin intervention in obese patients with type 2 diabetes may be beneficial.

Trial Registration: Thai clinical trials regentrify no.20140303003.

Citing Articles

Natural Bioactive Compounds in the Management of Type 2 Diabetes and Metabolic (Dysfunction)-Associated Steatotic Liver Disease.

Ciobarca D, Catoi A, Gavrilas L, Banc R, Miere D, Filip L Pharmaceuticals (Basel). 2025; 18(2).

PMID: 40006091 PMC: 11859434. DOI: 10.3390/ph18020279.

Integrative Roles of Functional Foods, Microbiotics, Nutrigenetics, and Nutrigenomics in Managing Type 2 Diabetes and Obesity.

Lam H, Lin S, Nguyen D, Chen C, Su C, Fang T Nutrients. 2025; 17(4).

PMID: 40004938 PMC: 11858703. DOI: 10.3390/nu17040608.

Repurposed Drugs and Plant-Derived Natural Products as Potential Host-Directed Therapeutic Candidates for Tuberculosis.

Raqib R, Sarker P Biomolecules. 2025; 14(12.

PMID: 39766204 PMC: 11673177. DOI: 10.3390/biom14121497.

References

Saadati S, Hatami B, Yari Z, Shahrbaf M, Eghtesad S, Mansour A . The effects of curcumin supplementation on liver enzymes, lipid profile, glucose homeostasis, and hepatic steatosis and fibrosis in patients with non-alcoholic fatty liver disease. Eur J Clin Nutr. 2019; 73(3):441-449. DOI: 10.1038/s41430-018-0382-9. View

Patti A, Al-Rasadi K, Katsiki N, Banerjee Y, Nikolic D, Vanella L . Effect of a Natural Supplement Containing Curcuma Longa, Guggul, and Chlorogenic Acid in Patients With Metabolic Syndrome. Angiology. 2015; 66(9):856-61. DOI: 10.1177/0003319714568792. View

. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016; 388(10053):1545-1602. PMC: 5055577. DOI: 10.1016/S0140-6736(16)31678-6. View

Rahimi H, Mohammadpour A, Dastani M, Jaafari M, Abnous K, Ghayour Mobarhan M . The effect of nano-curcumin on HbA1c, fasting blood glucose, and lipid profile in diabetic subjects: a randomized clinical trial. Avicenna J Phytomed. 2016; 6(5):567-577. PMC: 5052420. View

Chuengsamarn S, Rattanamongkolgul S, Jirawatnotai S . Association between serum uric acid level and microalbuminuria to chronic vascular complications in Thai patients with type 2 diabetes. J Diabetes Complications. 2014; 28(2):124-9. DOI: 10.1016/j.jdiacomp.2013.12.002. View

Na L, Li Y, Pan H, Zhou X, Sun D, Meng M . Curcuminoids exert glucose-lowering effect in type 2 diabetes by decreasing serum free fatty acids: a double-blind, placebo-controlled trial. Mol Nutr Food Res. 2012; 57(9):1569-77. DOI: 10.1002/mnfr.201200131. View

Elmansi A, El-Karef A, Shishtawy M, Eissa L . Hepatoprotective Effect of Curcumin on Hepatocellular Carcinoma Through Autophagic and Apoptic Pathways. Ann Hepatol. 2017; 16(4):607-618. DOI: 10.5604/01.3001.0010.0307. View

Adibian M, Hodaei H, Nikpayam O, Sohrab G, Hekmatdoost A, Hedayati M . The effects of curcumin supplementation on high-sensitivity C-reactive protein, serum adiponectin, and lipid profile in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial. Phytother Res. 2019; 33(5):1374-1383. DOI: 10.1002/ptr.6328. View

. Abridged for Primary Care Providers. Clin Diabetes. 2017; 35(1):5-26. PMC: 5241768. DOI: 10.2337/cd16-0067. View

10.

Griffiths K, Aggarwal B, Singh R, Buttar H, Wilson D, De Meester F . Food Antioxidants and Their Anti-Inflammatory Properties: A Potential Role in Cardiovascular Diseases and Cancer Prevention. Diseases. 2017; 4(3). PMC: 5456284. DOI: 10.3390/diseases4030028. View

11.

Dupont W, Plummer Jr W . Power and sample size calculations for studies involving linear regression. Control Clin Trials. 1999; 19(6):589-601. DOI: 10.1016/s0197-2456(98)00037-3. View

12.

Trujillo J, Chirino Y, Molina-Jijon E, Anderica-Romero A, Tapia E, Pedraza-Chaverri J . Renoprotective effect of the antioxidant curcumin: Recent findings. Redox Biol. 2013; 1:448-56. PMC: 3814973. DOI: 10.1016/j.redox.2013.09.003. View

13.

Kelany M, Hakami T, Omar A . Curcumin improves the metabolic syndrome in high-fructose-diet-fed rats: role of TNF-α, NF-κB, and oxidative stress. Can J Physiol Pharmacol. 2016; 95(2):140-150. DOI: 10.1139/cjpp-2016-0152. View

14.

Panahi Y, Khalili N, Sahebi E, Namazi S, Saberi Karimian M, Majeed M . Antioxidant effects of curcuminoids in patients with type 2 diabetes mellitus: a randomized controlled trial. Inflammopharmacology. 2016; 25(1):25-31. DOI: 10.1007/s10787-016-0301-4. View

15.

Asadi S, Gholami M, Siassi F, Qorbani M, Khamoshian K, Sotoudeh G . Nano curcumin supplementation reduced the severity of diabetic sensorimotor polyneuropathy in patients with type 2 diabetes mellitus: A randomized double-blind placebo- controlled clinical trial. Complement Ther Med. 2019; 43:253-260. DOI: 10.1016/j.ctim.2019.02.014. View

16.

Prasad S, Gupta S, Tyagi A, Aggarwal B . Curcumin, a component of golden spice: from bedside to bench and back. Biotechnol Adv. 2014; 32(6):1053-64. DOI: 10.1016/j.biotechadv.2014.04.004. View

17.

. Executive summary: Standards of medical care in diabetes--2013. Diabetes Care. 2012; 36 Suppl 1:S4-10. PMC: 3537272. DOI: 10.2337/dc13-S004. View

18.

Gulati O . Pycnogenol® in Metabolic Syndrome and Related Disorders. Phytother Res. 2015; 29(7):949-68. DOI: 10.1002/ptr.5341. View

19.

Huang M, Deng S, Han Q, Zhao P, Zhou Q, Zheng S . Hypoglycemic Activity and the Potential Mechanism of the Flavonoid Rich Extract from Sophora tonkinensis Gagnep. in KK-Ay Mice. Front Pharmacol. 2016; 7:288. PMC: 5011294. DOI: 10.3389/fphar.2016.00288. View

20.

Chuengsamarn S, Rattanamongkolgul S, Phonrat B, Tungtrongchitr R, Jirawatnotai S . Reduction of atherogenic risk in patients with type 2 diabetes by curcuminoid extract: a randomized controlled trial. J Nutr Biochem. 2014; 25(2):144-50. DOI: 10.1016/j.jnutbio.2013.09.013. View